Johnson & Johnson said on Monday it was expecting to retain a stake of about 9.5% in its newly separated consumer health unit, Kenvue, after completing a share exchange offer.
Shares of the consumer health company rose 1.4% in premarket trading.
J&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff.
Source : Reuters
Christian Mumssen, the fund's new director of strategy, cited a rapid succession of major shocks…
Gold bounces from two-week low, markets await US inflation data. Gold ticked higher on Tuesday…
Reuters poll forecasts U.S. headline inflation at 3.8%. The dollar remained in sight of 13-month…
When Credit Suisse failed in March 2023, Swiss authorities, against market expectations, set aside the…
US labour productivity has accelerated since 2022. Output per hour grew around 2.5% per year…
Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing…